Related Experiment Video
Updated: Jul 18, 2026

Scoring Central Nervous System Inflammation, Demyelination, and Axon Injury in Experimental Autoimmune Encephalomyelitis
Published on: February 23, 2024
Herpes-simplex virus encephalitis is characterized by an early MMP-9 increase and collagen type IV degradation
Johann Sellner1, Franziska Simon, Uta Meyding-Lamade
1Department of Neurology, University Hospital Bern, Inselspital, Freiburgstrasse, CH-3010 Bern, Switzerland.
Insights
Matrix-metalloproteinase-9 (MMP-9) damages cerebral vasculature in herpes-simplex virus encephalitis (HSE). This breakdown of the neurovascular matrix contributes to severe complications, suggesting MMP-9 as a potential therapeutic target.
Area of Science:
- Neuroscience
- Virology
- Biochemistry
Background:
- Herpes-simplex virus encephalitis (HSE) causes severe neurological damage.
- Cerebrovascular complications like edema and hemorrhage are key contributors to HSE mortality.
- The neurovascular matrix, particularly collagen type IV, plays a critical role in brain tissue integrity.
Purpose of the Study:
- To investigate the role of matrix-degrading enzymes, specifically matrix-metalloproteinase-9 (MMP-9), in the pathogenesis of HSE.
- To examine changes in collagen type IV and MMP-9 expression and localization during HSE development.
- To understand the relationship between MMP-9 activity, its inhibitor TIMP-1, and neurovascular damage in HSE.
Main Methods:
- Utilized an experimental model of focal HSE.
- Assessed MMP-9 levels at early (3 days) and acute (7 days) stages of HSE.
- Employed in situ zymography to determine the spatial distribution of MMP-9 activity in brain sections.
- Quantified collagen type IV and TIMP-1 levels around the cerebral vasculature.
Main Results:
- Significantly elevated MMP-9 levels were observed in both early and acute stages of HSE.
- MMP-9 activity was localized to cerebral vasculature and expanded to perivascular spaces in later stages.
- MMP-9 activity exceeded TIMP-1's inhibitory capacity, leading to collagen type IV degradation.
- Evidence of neurovascular matrix damage was found in HSE.
Conclusions:
- MMP-9 plays a crucial role in the progression of HSE by degrading the cerebral vasculature.
- Damage to the neurovascular matrix by MMP-9 contributes to cerebrovascular complications in HSE.
- Targeting MMP-9 may offer a novel therapeutic strategy for managing HSE and its associated complications.
Abstract:
Cerebrovascular complications including cerebral edema, raised intracranial pressure and hemorrhage contribute to the high mortality and morbidity of herpes-simplex virus encephalitis (HSE). We examined changes of collagen type IV, the major constituent of the neurovascular matrix, together with expression and localization of matrix-degrading enzymes during the development of acute HSE. In an experimental model of focal HSE, we found that early, symptomatic HSE (3 days after infection) and acute, fully developed HSE (7 days after infection) are associated with significantly raised levels of matrix-metalloproteinase-9 (MMP-9) (both P<0.05). In situ zymography of brain sections revealed that the increase of MMP-9 was restricted to the cerebral vasculature in early HSE and further expanded towards the perivascular space and adjacent tissue in acute HSE. Around the cerebral vasculature, we observed that MMP-9 activity was insufficiently counterbalanced by its endogenous tissue inhibitor of MMP (TIMP) TIMP-1, resulting in loss of collagen type IV. Our findings suggest that MMP-9 is involved in the evolution of HSE by causing damage to the cerebral vasculature. The degradation of the neurovascular matrix in HSE facilitates the development of cerebrovascular complications and may represent a target for novel adjuvant treatment strategies.
Related Concept Videos
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Arboviral Encephalitis
Herpes
Bacterial Meningitis II: Pathophysiology
Bacterial Meningitis

